EC approves Sanofi and Regeneron’s Dupixent for severe asthma in children
The expanded authorisation is based on findings from the Phase III VOYAGE trial of Dupixent.

The expanded authorisation is based on findings from the Phase III VOYAGE trial of Dupixent.
RSVpreF is intended for the active vaccination of pregnant women to prevent lower respiratory tract illness linked to RSV in…
The recommendation is based on data from the Phase III trial, in which Dupixent reduced the rate of severe asthma…
The regulatory agency sought further data linked to the measurement of efficacy.
Australia’s health minister said Novavax’s coronavirus jab, Nuvaxovid, should be available from February 21.
ByWith booster programmes underway across the globe, researchers are exploring which vaccine combinations could be most effective.
ByModerna CEO Stéphane Bancel also said an Omicron-specific Covid-19 vaccine will enter clinical development in a matter of weeks.
ByVertex Pharmaceuticals’ Trikafta/Kaftrio is currently the world’s first triple-combination cystic fibrosis therapy.
ByThank you for subscribing to Pharmaceutical Technology